348122 <common-name>(5z)-3-cyclopentyl-5-[[3-[4-(2-methylpropoxy)phenyl]-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-3-cyclopentyl-5-[[3-[4-(2-methylpropoxy)phenyl]-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C28H29N3O2S2. With an average molecular weight of 503.70 g/mol, (5z)-3-cyclopentyl-5-[[3-[4-(2-methylpropoxy)phenyl]-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>624724-28-3</cas> <pubchem-id>5917580</pubchem-id> <chemical-formula>C28H29N3O2S2</chemical-formula> <weight>503.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T12:01:27Z</created-at> <updated-at type="dateTime">2026-08-31T12:01:27Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)COC1=CC=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)C4CCCC4)C5=CC=CC=C5</moldb-smiles> <moldb-formula>C28H29N3O2S2</moldb-formula> <moldb-inchi>InChI=1S/C28H29N3O2S2/c1-19(2)18-33-24-14-12-20(13-15-24)26-21(17-30(29-26)22-8-4-3-5-9-22)16-25-27(32)31(28(34)35-25)23-10-6-7-11-23/h3-5,8-9,12-17,19,23H,6-7,10-11,18H2,1-2H3/b25-16-</moldb-inchi> <moldb-inchikey>VKEQZIBGGDBOLD-XYGWBWBKSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">503.1701195</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM344015</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-3-cyclopentyl-5-[[3-[4-(2-methylpropoxy)phenyl]-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298457</sync-id> <structure-inchikey>VKEQZIBGGDBOLD-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000400000800042000200000000000000000000000100000000020000405000000020300000000000002004000000000000000000810000000000000000000000000000000200000000000020000010000300000200000000000000000000000000000000000100010020800008020100008040000000000000100800004140000000800000000000000000800000000100000000000000000000000000000004000010000000080000000000000004090000020200040000000000000000000000000000000000000000000000000000040000000202000000002000000040000100000040000000820020000000080000000040000200000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDBgBgAAAAAgIIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAdAKAAA AAMDB0AoAAAAAwMGQGgAAAADAwEGQCgAAAADBAYAaAAAAAMDAQYAKAAAAAME BgAoAAAAAwQIACgAAAADAgcAKAAAAAMDBgAoAAAAAwQQACgAAAADAhAAIAAA AAIGAGAAAAADAQYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgA AAADAwELAAEAAQIAAQMAAwQABAUgBQZoDAYHaAwHCGgMCAloDAkKaAwICyAL DGgMDA1oDA0OaAwOD2gMDxAgEBEoAhESIBITKAISFCAUFSAVFigCFRcAFBgA GBkAGRoAGhsAGxwADR0gHR5oDB4faAwfIGgMICFoDCEiaAwKBWgMDwtoDBcR ABwYACIdaAxCBQAAAAYFCgkIBwYFDAsPDg0FEhEXFRQFGRgcGxoGHh8gISId FwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:36Z</structure-indexed-at> </compound>